27 - Pediatric COVID-19 Vaccines

Thursday, October 20, 2022

10:30 AM – 11:45 AM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Nadine Rouphael, MD

Professor of Medicine- Director of the Hope Clinic
Division of Infectious Diseases, Department of Medicine
Emory University School of Medicine
Atlanta, Georgia, United States

Disclosure(s): Emmes: Advisor/Consultant (Ongoing); ICON: Advisor/Consultant (Ongoing)
Lisa Jackson, MD, MPH

Senior Investigator
Kaiser Permanente Washington Health Research Institute
Seattle, WA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Evan Anderson, MD

Professor
Pediatrics and Medicine
Emory University School of Medicine
Atlanta, Georgia, United States

Disclosure(s): GSK: Advisor/Consultant (), Grant/Research Support (); Janssen: Advisor/Consultant (), Grant/Research Support (); Kentucky Bioprocessing, Inc: Data Safety Monitoring Board (); MedImmune: Grant/Research Support (); Medscape: Advisor/Consultant (); Merck: Grant/Research Support (); Micron: Grant/Research Support (); NIH: Funding from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines (); PaxVax: Grant/Research Support (); Pfizer: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); Sanofi Pasteur: Advisor/Consultant (), Data Adjudication and Data Safety Monitoring Boards (), Grant/Research Support (); WCG and ACI Clinical: Data Adjudication Board ()

Slides
Ruth Link-Gelles, PhD, MPH

Epidemiologist
Centers for Disease Control and Prevention
Atlanta, GA, United States

Disclosure(s): Abbott Laboratories: Stocks/Bonds (Ongoing)

Slides
Matthew Oster, MD, MPH

Pediatric Cardiologist
Children's Healthcare of Atlanta, GA, United States

Disclosure(s): Pfizer: Grant/Research Support (Ongoing)

Slides

Disclosure(s):

Nadine Rouphael, MD: Emmes: Advisor/Consultant (Ongoing); ICON: Advisor/Consultant (Ongoing)

Lisa Jackson, MD, MPH: No financial relationships to disclose

Evan J. Anderson, MD: GSK: Advisor/Consultant (), Grant/Research Support (); Janssen: Advisor/Consultant (), Grant/Research Support (); Kentucky Bioprocessing, Inc: Data Safety Monitoring Board (); MedImmune: Grant/Research Support (); Medscape: Advisor/Consultant (); Merck: Grant/Research Support (); Micron: Grant/Research Support (); NIH: Funding from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines (); PaxVax: Grant/Research Support (); Pfizer: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); Sanofi Pasteur: Advisor/Consultant (), Data Adjudication and Data Safety Monitoring Boards (), Grant/Research Support (); WCG and ACI Clinical: Data Adjudication Board ()

Ruth Link-Gelles, PhD, MPH: Abbott Laboratories: Stocks/Bonds (Ongoing)

Matthew Oster, MD, MPH: Pfizer: Grant/Research Support (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

characterize the risk of myocarditis following COVID-19 vaccines in children;
summarize the data from observational studies on COVID-19 vaccine effectiveness in the United States and elsewhere;
describe the safety and efficacy data from randomized clinical trials of COVID-19 vaccines in children

Presentations:

10:30 AM – 10:55 AM US ET

The Data Supporting Pediatric COVID-19 Vaccination
Speaker: Evan J. Anderson, MD – Emory University School of Medicine
10:55 AM – 11:20 AM US ET

Real-World Effectiveness of COVID-19 Vaccines
Speaker: Ruth Link-Gelles, PhD, MPH – Centers for Disease Control and Prevention
11:20 AM – 11:45 AM US ET

Myocarditis and COVID-19 Vaccines
Speaker: Matthew Oster, MD, MPH – Children's Healthcare of Atlanta